Protease Inhibitor Phenotype BsaskatoonM Is Not Associated with Emphysema – A 20-Year Follow-Up Study
OBJECTIVE: To investigate the association between the PiBsaskatoon variant of alpha-1 protease inhibitor (α1 Pi), present in the heterozygous state and the development of emphysema.
Saved in:
| Main Authors: | Ruzica Jokic, Kendra L Fisher, Donald W Cockcroft |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/1999/409016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Normal Expiratory Flow Rate and Lung Volumes in Patients with Combined Emphysema and Interstitial Lung Disease: A Case Series and Literature Review
by: Karen L Heathcote, et al.
Published: (2011-01-01) -
Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
by: Luca Musante, et al.
Published: (2015-01-01) -
Lung function and peak oxygen uptake in chronic obstructive pulmonary disease phenotypes with and without emphysema.
by: Øystein Rasch-Halvorsen, et al.
Published: (2021-01-01) -
Differentiating Emphysema From Emphysema-Dominated COPD Patients with CT Imaging Feature and Machine Learning
by: Guo W, et al.
Published: (2025-07-01) -
Evaluation of COVID-19 protease and HIV inhibitors interactions
by: Tran Linh, et al.
Published: (2022-03-01)